Abstract
IntroductionHepatocellular carcinoma (HCC) is a leading cause of cancer-related death in China. The combination of immune checkpoint inhibitors (ICIs) and antiangiogenic drugs, such as bevacizumab and tyrosine kinase inhibitors, has...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have